Cambridge Investment Research Advisors’s NRX Pharmaceuticals NRXP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,352	Closed	-$1.42M	–	3244
2021 Q3	$1.42M	Buy	+15,352	New	+$1.42M	0.01%	1286